Is Iovance Biotherapeutics a Millionaire Maker?
Biotech stocks like Iovance Biotherapeutics (NASDAQ: IOVA) often look appealing because they could experience enormous growth in relatively short periods of time. Plus, over the long term, successful biotech companies have the opportunity to blossom into larger and larger versions, sometimes eventually joining the ranks of big pharmaceutical companies. And if a patient investor can get in on the ground level, it might just be possible to turn a small investment into millions.
Is there such an opportunity with Iovance? Let's sketch out the path it would need to take.
Given its market cap of about $2.4 billion, the path for Iovance to make investors into millionaires is, at best, a very long one. Let's lay out a few assumptions about how much it needs to grow, then test to see if those assumptions are realistic.
Source Fool.com
